bioAffinity Technologies (BIAF) Earnings Analysis

bioAffinity Technologies (BIAF) next reports earnings on 2026-08-19, consensus EPS -2.1 USD. Last quarter (2026-05-08) it beat with EPS -0.81 USD vs -2.4 USD est (+66.3%). It has beaten estimates in 4/8 recent quarters (50%). Trailing P/E -0.06.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does BIAF next report earnings?

Next earnings date2026-08-19
Consensus EPS estimate-2.1 USD
Revenue estimate0.00B

BIAF earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-05-08-0.81 USD-2.4 USD+66.3%Beat
2026-03-13-1.11 USD-2.7 USD+58.9%Beat
2025-11-14-2.7 USD-2.7 USD0%Beat
2025-08-14-3.9 USD-2.7 USD-44.4%Miss
2025-05-15-0.16 USD-0.16 USD0%Beat
2025-03-31-0.21 USD-0.14 USD-50%Miss
2024-11-14-0.16 USD-0.15 USD-6.7%Miss
2024-08-14-0.19 USD-0.17 USD-11.8%Miss

Beat rate: 4/8 (50%) over reported quarters with consensus data.

BIAF valuation and analyst view

Trailing P/E-0.06
Trailing EPS-3.533 USD
Price / book0.87
Dividend yield0.00%
Market cap0.00B
Analyst consensusHold (0 buy / 1 hold / 0 sell)

Related research pages

Frequently asked questions

When is bioAffinity Technologies (BIAF)'s next earnings date?

bioAffinity Technologies is next scheduled to report on 2026-08-19, with a consensus EPS estimate of -2.1 USD and revenue estimate of 0.00B.

Did BIAF beat earnings last quarter?

In its 2026-05-08 report, BIAF posted EPS of -0.81 USD versus a -2.4 USD estimate — a beat of 66.3%.

What is BIAF's earnings track record?

Over the last 8 reported quarters with consensus data, BIAF beat estimates 4 times (50%).

What is BIAF's current P/E ratio and EPS?

BIAF trades at a trailing P/E of -0.06 on trailing EPS of -3.5329973711564064 USD.

What do analysts rate BIAF?

Analyst consensus is "Hold" across 1 ratings (0 strong buy, 0 buy, 1 hold, 0 sell, 0 strong sell).